Skip to main content

Table 1 Basic characteristics of infant patients

From: Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants

 

Vancomycin-lock group (n = 68)

Control group (n = 69)

p value

Gender (male, n (%))

42 (61.8)

34 (49.3)

0.170*

Gestational age, Wk

29.8 ± 1.90

30.1 ± 2.33

0.323

Birth weight, Kg

1.2 ± 0.19

1.3 ± 0.23

0.765

5-min APGAR score

8.29 ± 1.04

8.7 ± 0.71

0.010

Comorbilities

 Neonatal sepsis, n (%)

43 (63.2)

42 (60.9)

0.861*

 NRDS, n (%)

46 (67.6)

44 (63.8)

0.720*

 PDA, n (%)

30 (44.1)

31 (44.9)

1.000*

 IVH, n (%)

11 (16.2)

16 (23.2)

0.391*

 NEC, n (%)

6 (8.8)

7 (10.1)

1.000*

 Meningitis, n (%)

4 (5.9)

15 (21.7)

0.012*

PROM time, h

40.2 ± 114

45.3 ± 92.9

0.776

MV time, d

12.8 ± 13.1

17.0 ± 17.9

0.115

PICC time, d

33.0 ± 12.7

33.7 ± 19.6

0.798

TPN or PPN time, d

35.2 ± 15.7

33.9 ± 17.8

0.660

Hospital stay, d

48.3 ± 16.6

51.8 ± 28.2

0.376

Hospitalization costs, RMB (Yuan)

110,000 ± 53,000

118,000 ± 80,000

0.491

  1. Note: *showed chi-square test, and other analysis was t-test; NRDS neonatal respiratory distress syndrome, PDA patent ductus arteriosus, IVH intraventricular hemorrhage, NEC necrotizing enterocolitis, PROM premature rupture of membrane, MV mechanical ventilation, PICC peripherally inserted central catheters, TPN total parenteral nutrition, PPN part parenteral nutrition